This Is How the Food Industry Is Preparing For a Post-Ozempic World
The rise of GLP-1 drugs, like Ozempic, is a potentially existential threat to the makers of salty, sugary, high-calorie snack foods. But it's obvious that the gigantic food industry will search out ways to adapt. So what types of new products will they sell? How will they be flavored? How will they be packaged and…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like Odd Lots →
How Big Food Is Navigating the GLP-1 Era
The Big Business Behind Weight Loss Drugs
GLP-1 Pills Are On The Way. Here's What To Know
Can WeightWatchers survive the Wegovy era?
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.